Substance Use Disorder Treatment Market

By Treatment;

Detoxification, Counselling & Behavioral Therapy, Medication, and Support Group

By Type;

Alcohol Abuse Treatment, Nicotine Abuse Treatment, and Drug Abuse Treatment

By Substance Dependency;

Alcohol Use Disorder and Opioid Use Disorder

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn104089634 Published Date: August, 2025

Substance Use Disorder Treatment Market Overview

Substance Use Disorder Treatment Market (USD Million)

Substance Use Disorder Treatment Market was valued at USD 11,995.07 million in the year 2024. The size of this market is expected to increase to USD 17,646.75 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.7%.


Substance Use Disorder Treatment Market

*Market size in USD million

CAGR 5.7 %


Study Period2025 - 2031
Base Year2024
CAGR (%)5.7 %
Market Size (2024)USD 11,995.07 Million
Market Size (2031)USD 17,646.75 Million
Market ConcentrationMedium
Report Pages316
11,995.07
2024
17,646.75
2031

Major Players

  • Teva Pharmaceutical Industries Ltd
  • Alkermes plc.
  • Reckitt Benckiser Pharmaceuticals Inc.
  • GlaxoSmithKline plc.
  • Pfizer, Inc.
  • Cipla Limited
  • Intas Biopharmaceuticals
  • Indivior PLC and Opiant Pharmaceuticals
  • Sahyog Clinic,
  • Pear Therapeutics, Inc. and Sandoz,

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Substance Use Disorder Treatment Market

Fragmented - Highly competitive market without dominant players


The Substance Use Disorder Treatment Market is expanding as treatment centers and clinicians increasingly adopt comprehensive care models, integrating medication-assisted therapy and behavioral support in a single pathway. Nearly 65% of rehabilitation programs now utilize combined medication and psychotherapy approaches. This comprehensive model is advancing innovation and market expansion, supported by close collaboration between addiction specialists and pharmaceutical developers.

Enhanced Treatment Regimens with Digital Tools
Around 62% of treatment providers are enhancing regimens with features such as extended-release formulations, telehealth support, digital adherence tools, and integrated counseling modules. These are critical technological advancements that enhance patient engagement and treatment consistency. Joint efforts between behavioral health experts and tech innovators are enabling more effective interventions.

Data‑Driven Protocols Boosting Clinical Effectiveness
Coordinated programs between addiction clinics, mental health professionals, and research universities have led to a 59% rise in adoption of data-driven treatment plans and outcome tracking systems. These cross-functional collaborations ensure evidence-based protocols, personalized therapy adjustments, and monitoring strategies—leading to growth through unified care pathways.

Alliances Enhancing Access and Support Services
Approximately 63% of recent progression stems from strategic partnerships and brand licensing between treatment center networks, pharmaceutical firms, and digital health solution providers. These alliances broaden treatment accessibility, improve patient support infrastructure, and enhance continuity of care—fuelling consistent market expansion.

In this report, the Substance Use Disorder Treatment Market has been segmented by Treatment, Type, Substance Dependency, and Geography.

Substance Use Disorder Treatment Market, Segmentation by Treatment

The Substance Use Disorder Treatment Market has been segmented by Treatment into Detoxification, Counselling & Behavioral therapy and Medication & Support group.

Detoxification

In this phase patients undergo medically supervised withdrawal, often with medications to manage withdrawal symptoms and reduce health risks. This segment accounts for roughly 20–25% of the substance use disorder treatment market, serving as a critical gateway into comprehensive care.

Counselling & Behavioral Therapy

This sub‑segment includes cognitive‑behavioral therapy, motivational interviewing, and group counseling methods. Representing about 45–50% of the market, this approach focuses on behavior modification, emotional regulation, and developing long‑term recovery skills.

Medication & Support Group

This segment combines medication‑assisted treatment—such as methadone, buprenorphine, or naltrexone—with peer‑based

support groups

support groups like AA or NA. It makes up approximately 30–35% of the market and blends clinical efficacy with community‑driven relapse prevention.

Substance Use Disorder Treatment Market, Segmentation by Type

The Substance Use Disorder Treatment Market has been segmented by Alcohol Abuse Treatment, Nicotine Abuse Treatment, and Drug Abuse Treatment.

Alcohol Abuse Treatment

This segment delivers evidence‑based programs to combat alcohol dependence through a mix of behavioral therapy, medication‑assisted care, and relapse prevention. It captures around 40–45% of the global substance use disorder treatment market, driven by high incidence rates and growing access to rehabilitation services.

Nicotine Abuse Treatment

Focused on helping individuals quit tobacco and nicotine products, this sub‑segment employs behavioral counseling, nicotine replacement therapy, and FDA‑approved medications. Representing roughly 25–30% of the market, growth is fueled by public health campaigns and heightened awareness of smoking‑related health risks.

Drug Abuse Treatment

Covering interventions for illicit drugs and prescription misuse, this segment offers detoxification, medication‑assisted treatment, and behavioral counseling. Accounting for nearly 30–35% of the market, it is driven by the opioid crisis and the rise in synthetic drug abuse.

Substance Use Disorder Treatment Market, Segmentation by Substance Dependency

The Substance Use Disorder Treatment Market has been segmented by Alcohol Use Disorder and Opioid Use Disorder.

Alcohol Use Disorder

Treatment for alcohol dependence involves a combination of behavioral therapies, medication‑assisted care, and relapse prevention strategies. This segment holds roughly 45–50% of the global substance use disorder treatment market, driven by the high prevalence of alcohol misuse and greater access to rehabilitation programs. Integrated approaches often blend detoxification with ongoing psychological support for lasting recovery.

Opioid Use Disorder

Treatment for opioid dependence addresses both prescription opioid and illicit drug misuse using medication‑assisted treatment, behavioral counseling, and community support. Accounting for about 35–40% of the market, its rise is fueled by the opioid crisis and expanding public health initiatives. MAT options such as methadone, buprenorphine, and naltrexone are often paired with therapy to enhance recovery outcomes and reduce relapse.

Substance Use Disorder Treatment Market, Segmentation by Geography

In this report, the Substance Use Disorder Treatment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Regions and Countries Analyzed in this Report

Legend
North America
Rest of North America
Europe
Rest of Europe
Asia Pacific
Rest of Asia Pacific
Middle East and Africa
Rest of Middle East and Africa
Latin America
Rest of Latin America
Rest of the World

Substance Use Disorder Treatment Market Share (%), by Geographical Region

North America

Leading the global market with about 40–45% share, this region benefits from advanced healthcare systems, high public awareness, and significant government funding. The U.S. remains the largest contributor due to elevated rates of opioid and alcohol misuse and a strong network of rehabilitation centers.

Europe

Holding around 25–28% of the market, Europe thrives on public health strategies and growing adoption of evidence‑based therapies. The UK, Germany, and France lead investments in prevention programs and integrated care models for substance abuse treatment.

Asia Pacific

With nearly 18–22% of the market, Asia Pacific is experiencing rapid growth due to rising substance misuse rates in urban areas. Government initiatives, mental health awareness campaigns, and new treatment facilities are driving expansion.

Middle East and Africa

Accounting for about 7–9% of the market, this region is steadily improving its addiction treatment infrastructure. Increased awareness, policy reforms, and regional collaborations are helping expand access to recovery services.

Latin America

Representing roughly 6–8% of the global market, Latin America’s growth is led by Brazil and Mexico. Public health campaigns, NGO‑led rehabilitation programs, and better treatment accessibility are supporting steady development.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Treatment
    2. Market Snapshot, By Type
    3. Market Snapshot, By Substance Dependency
    4. Market Snapshot, By Region
  4. Substance Use Disorder Treatment Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Personalized Care

        2. Holistic Approach

        3. Patient-Centered Care

        4. Public Health Initiatives

      2. Restraints
        1. Workforce Shortages

        2. Co-occurring Disorders

        3. Limited Evidence Base

        4. Cultural and Linguistic Barriers

      3. Opportunities
        1. Holistic Wellness Programs

        2. Collaborative Care Models

        3. Workforce Development

        4. Integration with Primary Care

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Substance Use Disorder Treatment Market, By Treatment, 2021 - 2031 (USD Million)
      1. Detoxification
      2. Counselling & Behavioral Therapy
      3. Medication
      4. Support Group
    2. Substance Use Disorder Treatment Market, By Type, 2021 - 2031 (USD Million)
      1. Alcohol Abuse Treatment
      2. Nicotine Abuse Treatment
      3. Drug Abuse Treatment
    3. Substance Use Disorder Treatment Market, By Substance Dependency, 2021 - 2031 (USD Million)

      1. Alcohol Use Disorder

      2. Opioid Use Disorder

    4. Substance Use Disorder Treatment Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Teva Pharmaceutical Industries Ltd
      2. Alkermes plc.
      3. Reckitt Benckiser Pharmaceuticals Inc.
      4. GlaxoSmithKline plc.
      5. Pfizer, Inc.
      6. Cipla Limited
      7. Intas Biopharmaceuticals
      8. Indivior PLC and Opiant Pharmaceuticals
      9. Sahyog Clinic,
      10. Pear Therapeutics, Inc. and Sandoz,
  7. Analyst Views
  8. Future Outlook of the Market